KUALA LUMPUR, July 24 -- CSOP Asset Management Limited (CSOP) has announced the listing of the CSOP CSI 300 Index Daily (2X) Leveraged Product (7233.HK) and CSOP CSI 300 Index Daily (-1X) Inverse Product (7333.HK) on the Hong Kong Stock Exchange on July 27.
In a statement, Hong Kong’s largest leveraged and inverse products (L&I products) issuer, CSOP, said 7233.HK and 7333.HK would apply a swap-based synthetic replication strategy to achieve the respective investment objectives.
7233.HK will provide investment results closely corresponding to twice the daily performance of the CSI 300 Index while 7333.HK will provide investment results closely corresponding to inverse of the daily performance of the CSI 300 Index, both excluding costs and expenses.
Both priced at HKD 7, 7233.HK and 7333.HK will trade with lot size of 100, and the entry investment is about HKD 700.
As the first batch of China A-shares L&I products in Hong Kong, 7233.HK and 7333.HK have attracted about US$270 million initial investment upon inception in total. (US$1 = RM4.255)
China A-shares is the second largest equity market in the world after the United States equity market with a size of RMB 64.9 trillion.
The introduction of China A-shares L&I products in Hong Kong by CSOP will enable global investors to gain leveraged performance as well as hedge the downside risks of China A-shares in an easy and efficient manner.
-- BERNAMA
No comments:
Post a Comment